$35.22
1.474.36%
At close: -
$35.22
0.000.00%
After Hours: Feb 21, 4:00 PM EDT
Agios Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Agios Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $-1.94 | $-1.63 | -19.0 % |
Q3 | 2024-10-31 | $-1.43 | $1.11 | -228.8 % |
Q2 | 2024-08-01 | $-1.69 | $-1.59 | -6.29 % |
Q1 | 2024-05-02 | $-1.45 | $-1.65 | 12.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $10.70M | $9.35M | 14.4 % |
Q3 | 2024-10-31 | $8.96M | $9.46M | -5.24 % |
Q2 | 2024-08-01 | $8.62M | $9.75M | -11.6 % |
Q1 | 2024-05-02 | $8.19M | $8.37M | -2.16 % |
Agios Pharmaceuticals (AGIO) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
The Actual EPS was $-1.94, which missed the estimate of $-1.63.
The Actual Revenue was $10.7M, which beat the estimate of $9.3M.
Browse earnings estimates, EPS, and revenue on all stocks.